Nicholson G C, Kent J C, Gutteridge D H, Retallack R W
Clin Endocrinol (Oxf). 1985 May;22(5):597-609. doi: 10.1111/j.1365-2265.1985.tb02995.x.
Using two different cultured rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8) we have investigated the recently described cytoreceptor assay for 1,25-dihydroxyvitamin D (1,25-(OH)2D). The assay method is relatively simple and sensitive to 2.4 fmole per tube. Using either cell line, assay of serum samples, whose only preparation consisted of extraction and purification on a disposable diatomaceous earth column, produced variable values for serum 1,25-(OH)2D. Additional purification, using a disposable silicic acid minicolumn to remove other vitamin D metabolites resulted in consistent values and additional HPLC resulted in no further decrease in the values obtained. Our results show that a single two stage non-HPLC column can purify serum samples for assay in the cytoreceptor assay. The method is also applicable to the competitive protein binding assay employing calf thymus cytosol and the correlation between values obtained by both methods is highly significant. It is a sensitive, simple, and accurate method with technical advantages which allow greater sample throughput than other 1,25-(OH)2D assays.
我们使用两种不同的培养大鼠骨肉瘤细胞系(UMR 106和ROS 17/2.8),对最近描述的1,25 - 二羟基维生素D(1,25-(OH)₂D)细胞受体测定法进行了研究。该测定方法相对简单,每管对2.4飞摩尔敏感。使用任一细胞系,对血清样本进行测定时,其唯一的制备步骤是在一次性硅藻土柱上进行提取和纯化,血清1,25-(OH)₂D的值会出现变化。使用一次性硅酸微型柱进行额外纯化以去除其他维生素D代谢产物,可得到一致的值,而进一步的高效液相色谱法(HPLC)并未使所得值进一步降低。我们的结果表明,单个两阶段非HPLC柱可纯化血清样本用于细胞受体测定。该方法也适用于采用小牛胸腺胞液的竞争性蛋白结合测定,且两种方法所得值之间的相关性非常显著。它是一种灵敏、简单且准确的方法,具有技术优势,比其他1,25-(OH)₂D测定法能处理更多样本。